The microsurgery market size is estimated to be USD 2,547.12 million in 2022 and is expected to witness a CAGR of 5.87% during the forecast period 2023-2033. Rising surgical rates worldwide, ageing population, and escalating healthcare costs are some of the factors contributing to the market growth. Additionally, ongoing technological advancements and improvements in the field of microsurgery and rising prevalence of breast cancer, melanoma and non-melanoma skin cancer are other factors supporting the market growth. However, lack of skilled workforce and high price of surgery is expected to hinder the growth.

Ongoing technological advancements and improvements in the field of microsurgery is expected to propel the market growth during the forecast period. Some of the most recent advancements of microsurgery include the Endoscopic-Assisted Microsurgery (EAMS), Transoral Laser Microsurgery (TLM), Three-Dimensional On-Screen Microsurgery System (TOMS), and Transanal Endoscopic Microsurgery (TLM) super microsurgery. For instance, endoscopic and microsurgical techniques are frequently employed in the surgical treatment of brain tumors, and EAMS has technological benefits in the management of juvenile brain tumours in a variety of anatomical regions. EAMS is a practical, user-friendly technique that can be applied with microsurgery to treat these complex lesions.

Rising prevalence of breast cancer, melanoma and non-melanoma skin cancer is predicted to fuel the market growth during projected period. Barrette’s oesophagus and prostate cancer are two other conditions that require for microsurgical treatment. Both in both developed and developing countries, many people are getting on the cosmetic surgery bandwagon. Increasing purchasing power and a desire trying to appear and feel young are the primary motives of this desire. A lot of people try to resemble their favourite superstars. Additionally, they want to imitate their distinctive facial traits.

Segmentation

By Equipment

The market is categorized into micro sutures, operating microscopes, microsurgery needle holder, micro forceps, others. In the global market, the operating microscopes segment accounted for the largest revenue share in 2022 owing to the fact that the operating microscopes are employed widely in operating rooms and offer clear visibility of the surgical region, adjustable magnification, and bright illumination. Additionally, these microscopes enable medical practitioners to carry out difficult procedures and enhance the effectiveness of ophthalmic, plastic, and neurological procedures. Furthermore, the micro sutures market had a sizeable revenue share in 2022, and it is anticipated that it would increase at the highest rate throughout the forecast period. The fact that absorbable micro sutures naturally degrade can be attributed to their increasing usage. As a result, major players are engaging in R&D efforts, which could boost segment growth.

By Procedure

The market is divided into free tissue transfer, transplantation, suture and grafting, and others. In 2022, the free tissue transfer segment accounted for the highest revenue share due to rising use of microsurgery tools including forceps, sutures, and microscopes. In larger areas, the free tissue transfer method can restore both appearance and function. Under a microscope, this process is completed using accurate, tiny sutures. In 2022, the transplantation contributed significantly to revenue. The main factors expected to boost the growth of this segment include a rise in the number of kidney and heart transplant surgeries performed and soaring awareness levels about the benefits of the transplantation process, such as increased energy levels, increased lifespan, a better quality of life, and others. On the other hand, the neurology segment is anticipated to expand at the fastest rate over the projection period.

By Application

The market is segregated into neurology, plastic & reconstructive, ophthalmic, gynecological & urological microsurgery, oncology, orthopedic, and others. In the global market, the plastic & reconstructive segment accounted for the largest revenue share in 2022 owing to Growing public awareness of cosmetic procedures. Furthermore, it is projected that the demand for plastic surgery will increase as disposable income in developing economies rises. The segment will rise due to the increasing demand for plastic and reconstructive surgeries and the widespread use of microsurgery equipment in these procedures. In 2022, the ophthalmology segment contributed significantly as well. The demand for microsurgery equipment is projected to increase as ophthalmic treatments increase globally. The segment is anticipated to have profitable growth due to improvements in microsurgical technology and the expanding range of applications of surgical/operating microscopes in ophthalmology.

By End Use

The market is segmented into academics and research institutes, hospitals & clinics, ambulatory surgical centers, others. In 2022, the hospitals & clinics segment accounted for the largest revenue share owing to availability of hospitals for primary care in many developing nations and advantageous reimbursement conditions. According to estimates, the segment will rise as microsurgery equipment is used for more surgical procedures in hospital settings. The ASCs end-use segment is anticipated to increase at the fastest rate over the projection period. The primary driver that is predicted to boost demand for microsurgery equipment in ASCs is surge in the demand for same-day surgical due to advantages such a reduction in substantial cost savings & wait times. The ASC segment is then anticipated to grow as a result.

Regional Markets

In 2022, North America region accounted for the highest revenue in the microsurgery market and is expected to maintain its dominance during the forecast period. This is attributed to the existence of significant market participants in the U.S. and high prevalence of chronic diseases and disorders related to lifestyle. Manufacturers are also concentrating on the commercialization, development, and distribution of cutting-edge products, such as microsurgery equipment, to assist in meeting the requirements of medical professionals and surgeons. The projected period is expected to witness significant CAGR growth in the Europe region, which had the second-highest revenue share in 2022. The increase in the older population, who have issues related to chronic diseases that are more common, is driving the market expansion. The market has witnessed limited innovation from the established competitors, which has led to the arrival of new independent enterprises offering competitively priced high-quality items. APAC is predicted to experience the fastest CAGR due to increasing disposable income, faster GDP growth, and greater accessibility to healthcare.

Competitor Insights

Some of the key players operating in the microsurgery market are Scanlan International, Olympus Corp., Carl Zeiss AG, Accurate Surgical & Scientific Instruments Corp., B. Braun Melsungen Inc., Leica Microsystems, Surtex Instruments Ltd., Topcon Corp., HAAG-STREIT GROUP, KLS Martin Group, and Integra LifeSciences.

To achieve a competitive edge, these companies are implementing a variety of growth strategies. Strategic partnerships, alliances, and agreements with different businesses and research institutions are seen to be the main strategies used by companies in this sector.

• For instance, Haag-Streit announced that it will cease its surgical product portfolio in spine surgery, ENT, plastic-reconstructive surgery, and neurosurgery moving forward and instead concentrate its business on surgical microscopes in ophthalmology.

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including equipment, procedure, application, and end use from 2023 to 2033.

Report Scope:

Segmentation: Microsurgery Market Report 2022 – 2033

Equipment (Revenue, USD Million), 2022 – 2033

• Micro Sutures
• Operating Microscopes
• Microsurgery Needle Holder
• Micro Forceps
• Others

Procedure (Revenue, USD Million), 2022 – 2033

• Free Tissue Transfer
• Transplantation
• Suture and Grafting
• Others

Application (Revenue, USD Million), 2022 – 2033

• Neurology
• Plastic & Reconstructive
• Ophthalmic
• Gynecological & Urological Microsurgery
• Oncology
• Orthopedic
• Others

End Use (Revenue, USD Million), 2022 – 2033

• Academics and Research Institutes
• Hospitals & Clinics
• Ambulatory Surgical Centers
• Others

By Region (Revenue, USD Million), 2022 – 2033

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Rest of MEA